ARCHIVE ISSUES – MARCH 2021

The Journal of Precision Medicine - MARCH 2021

Transitioning from Emerging to Established Companies and Technologies

Integrating biomarker and translational research in a drug development pipeline

New Disruptive Business Model: The Convergence of Precision Science, Precision Medicine, Precision Product Development, and Precision Commercialization

Industry challenges & opportunities for the integration of precision medicine tools at the point of care

Building Back Better: Leveraging Value-Based Payment to Build a More Resilient Health Care System

Questions on an agnostic AI system: A case study for an aortic aneurysm detection and other applications

Implementing the ACMG Guidelines for CNV in a Commercial Software Solution

Revitalizing pharma’s drug discovery pipelines

The Parallel Diagnostic Odysseys of Alzheimer’s Disease and NASH

Multidimensional Predictive Diagnostics: The GPS of Clinical Practice

The Human Touch: Improving In Vivo Evaluation of Biologics with Human-ized Immune System Models

From Cerebral Cavernous Malformation to cancer research: a one-size-fits-all path to precision medicines

Letter to the Journal: The COVID-19 innovation race, a case study

Personalized Medicine and Disease Modification in Osteoarthritis: On our journey but still a way to go!

BACK TO ARCHIVE